Repealing the Trump Sick Tax Act

This bill would undo recent changes to Medicaid cost sharing rules and to how “orphan drugs” (medicines for rare diseases) are treated in Medicare’s drug price negotiation program. It would put the old rules back in place, as if the recent changes never happened, and pull back money that had been set aside to carry out those changes .

In practice, this means Medicaid copays and other out-of-pocket rules would return to what they were before, and the treatment of orphan drugs in Medicare’s negotiation program would also go back to the earlier approach .

• Who is affected | What changes | When
• Medicaid patients and families; people who use rare-disease drugs; state Medicaid programs; Medicare drug program | Restores previous Medicaid cost-sharing rules; restores the earlier rules for how orphan drugs are handled in Medicare’s drug price negotiations; rescinds funding tied to the now-repealed changes | Would take effect by reverting to the prior rules once enacted